Información:
Error:
ID
34308
Descripción
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01598740
Link
https://clinicaltrials.gov/show/NCT01598740
Palabras clave
Versiones (1)
- 16/1/19 16/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Heart Failure NCT01598740
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
heart failure with new york heart association (nyha) classification ii or iii
boolean
ID.2
Item
chronic kidney disease
boolean
ID.3
Item
cardiac ejection fraction <40%
boolean
ID.4
Item
on heart failure therapy including an acei or arb, and a bb
boolean
ID.5
Item
willing to understand and comply with study procedures and provide written informed consent.
boolean
ID.6
Item
hospitalization within 4 weeks of baseline visit
boolean
ID.7
Item
history or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
boolean
ID.8
Item
current or anticipated dialysis during study
boolean
ID.9
Item
in the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological, or other disease or condition that makes the subject's study participation unsafe
boolean
ID.10
Item
drug or alcohol abuse
boolean